Category Archives: Mental Health

Elderly Mental Health.

NICE Update on Antipsychotics for People With Dementia (NICE)

Posted on March 28, 2019 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence (NICE) has again updated their summary of evidence on the use (or withdrawal) of antipsychotics for people living with dementia. This document is not a formal NICE guideline. Full Text Link … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, SCIE, Systematic Reviews, UK, Universal Interest | Tagged Alive Approach to Provision of Meaningful Activities for Older People Living in Care, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotic Prescribing in Primary Care, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics in People With Dementia, Antipsychotics in People With Dementia: Key Therapeutic Topic [KTT7], Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Inappropriate Use of Antipsychotics in Dementia, Later Life, Long Term Plan (LTP), Medicines Optimisation, Mellifont Abbey Residential Care Home, Mental Health and Illness, Milton Keynes Primary Care Trust, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE)’s Quality Standard on Dementia: 2019 Draft For Consultation, Neurological Disorders, NHS England Medicines Optimisation Intelligence Group, NICE Key Therapeutic Topic [KTT7], NICE Key Therapeutic Topics, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Social Care Institute for Excellence (SCIE) | Leave a comment

Pharmacists’ Interventions to Promote Quality of Life and Healthy Ageing (PHE)

Posted on March 24, 2019 by Dementia and Elderly Care News

Summary Interventions which can be provided by pharmacy teams to help older people lead more independent lives and improve their health are listed, including those directed towards: Preventing falls. Dementia Physical inactivity. Social isolation. Malnutrition. Full Text Link Reference A … Continue reading →

Posted in Commissioning, Community Care, Diagnosis, Falls, Falls Prevention, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Public Health England, Quick Insights, Standards, UK, Universal Interest | Tagged Alcohol, Alcohol or Substance Misuse, Blood Pressure and Atrial Fibrillation, Centre for Pharmacy Postgraduate Education (CPPE), Commissioning Community Pharmacy, Commissioning of Pharmacy Services, Community Pharmacies, Community Pharmacies: Promoting Health and Wellbeing. NICE Guideline [NG102] (NICE), Community Pharmacists, Community Pharmacy, Community Pharmacy and Public Health, Community Pharmacy Teams, Community Pharmacy: Interventions for Public Health, Community Pharmacy: Public Health Interventions, Contribution Community Pharmacy to Public Health, Dementia Friendly Pharmacy Practice: Seven Steps, Dementia Friendly Pharmacy Practices, Dementia Risk Reduction, Dementia-Friendly Community Pharmacies, Dementia-Friendly Pharmacies, Diet and Nutrition, Diet and Obesity, Dorset’s Nutritional Care Strategy for Adults, Eatwell Guide For Healthy Eating, Elderly Malnutrition, Falls and Musculoskeletal Health, Five Ways to Wellbeing Framework, Health and Quality of Life, Healthy Ageing, Healthy Ageing: Pharmacist Interventions for Quality of Life, Healthy Living Pharmacies (HLPs), Hypertension, Improving Public Mental Health, Improving Referral Pathways, Later Life, Local Medical Committees (LMCs), Local Pharmaceutical Committees (LPCs), Local Professional Networks (LPNs), Loneliness and Social Isolation, Making Every Contact Count (MECC), Malnutrition, Malnutrition in Later Life, Malnutrition in the Community, MECC Plus, Menu of Interventions (MOIs) for Productive Healthy Ageing, NHS Health Check Programme, NHS Long Term Plan (2019), Oral Health, Pharmacies, Pharmacist Interventions for Quality of Life, Pharmacist Involvement, Pharmacy for Public Health, Pharmacy Teams in Different Settings, PHE: Public Health England, Physical Activity, Physical Activity and Health Benefits, Physical Activity Guidelines for Adults, Physical Activity Recommendations, Physical Inactivity, Primary Care Network (PCN) Contract, Productive Healthy Ageing: Pharmacist Interventions for Quality of Life, Public Health, Public Health England (PHE), Public Mental Health, Quality of Life, Quality of Life For Older People, Reablement Services, Reducing Social Isolation, Seven Steps to Becoming a Dementia Friendly Pharmacy Practice, Social Connectedness, Social Isolation, Substance Misuse, Tackling Loneliness and Social Isolation: Role of Pharmacists, Tobacco | Leave a comment

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Roadmap for Dementia Research (International Journal of Geriatric Psychiatry / Alzheimer’s Society)

Posted on February 26, 2019 by Dementia and Elderly Care News

Summary Moving beyond the concentration upon research devoted to the discovery of pharmacological interventions for the treatment of dementia / Alzheimer’s Disease, the authors instead worked on a roadmap of complementary (non-pharmacological) research ambitions in the areas of prevention, diagnosis, … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest, Wales | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Alzheimer's Society, Alzheimer’s Society Research Network, Bangor University, Barriers to Support, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Research in Ageing and Cognitive Health: University of Exeter, Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia 2020 Challenge: 2018 Review Phase 1 (DHSC), Dementia Research, Dementia Research Priorities, Dementia Research Proposals, Dementia Services Development Centre: Bangor University, Division of Psychiatry: University College London, Enabling Dementia Workforce to Deliver Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Increasing Knowledge of Risk and Protective Factors, Institute for Ageing: Newcastle University, Institute for Health and Society: Newcastle University, International Journal of Geriatric Psychiatry, Katherine Cowan Consulting Ltd, Kings College London, London School of Economics and Political Science, LSE's Personal Social Services Research Unit (PSSRU), Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, National Dementia Strategies (UK), Newcastle University, Optimising Quality and Inclusivity of Health and Social Care Systems to Support People Affected by Dementia, Personal Social Service Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, PSSRU at LSE, PSSRU: London School of Economics and Political Science, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Research Networks, Risk and Protective Factors, Roadmap to Advance Dementia Research by 2025 (Alzheimer’s Society), Roadmap to Advance Dementia Research by 2025: Care, Roadmap to Advance Dementia Research by 2025: Diagnosis, Roadmap to Advance Dementia Research by 2025: Interventions, Roadmap to Advance Dementia Research by 2025: Prevention, School of Clinical Medicine: University of Cambridge, Social Care Workforce Research Unit: King’s College London, Supporting People Affected by Dementia, University College London, University of Cambridge, University of Exeter, University of Exeter Medical School: University of Exeter, University of Sussex | Leave a comment

Latest Dementia Assessment and Referral Data for 2018 (NHS England)

Posted on February 14, 2019 by Dementia and Elderly Care News

Summary NHS England has published dementia assessment and referral statistics, as of November 2018. These statistics aim to monitor and improve (i) the identification of older patients with dementia and delirium, (ii) assessment and appropriate referral and (iii) follow-up after people have been … Continue reading →

Posted in Acute Hospitals, Commissioning, Community Care, Delirium, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Acute Care, Acute Hospitals, Acute Trusts, Acute Trusts: Find and Assess/Investigate Measures, Assessment, Assessment and Referral, Case Finding, Case Finding for Patients with Dementia, Checks for Dementia at Age 75 Years, Clinical Commissioning Group (CCG): Refer/Inform Measures, Clinical Commissioning Groups (CCGs), Community and Mental Health Trusts, Community Service Providers, Community Service Providers (Community and Mental Health Trusts), Community Services, Community Services Providers, Dementia Assessment and Referral 2015-16, Dementia Assessment and Referral Data, Dementia Assessment and Referral Data Collection, Dementia Assessment and Referral Statistics, Dementia Care in Acute General Hospital, Dementia Care in Acute Settings, Dementia Care in Emergency Departments, Dementia Care in General Hospitals, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Commissioning for Quality and Innovation (CQUIN), Dementia CQUIN, Dementia CQUIN: FAIR (Find; Assess and Investigate; Refer), Dementia Diagnostic Assessment, Dementia Friendly Acute Hospitals, Dementia Liaison Services, Dementia Statistics, Diagnosis and Referral, Discharge Planning, Early Diagnosis, FAIR (Find; Assess and Investigate; Refer), FAIRI: Find Assess/Investigate Refer/Inform, FAR: Find Assess Refer, General Hospitals, General Practice, General Practice Performance Data, Identification and Referral, Incentive Payments, Liaison Mental Health Services, Liaison Psychiatry Services, Liaison Services, Mental Health and Community Services, National Commissioning for Quality and Innovation (CQUIN) Payment Framework, National Commissioning for Quality and Innovation “CQUIN” Payment Framework (Department of Health), National Dementia CQUIN, Performance Incentives, Referral and Assessment, Referrals, Timely Diagnosis | Leave a comment

Draft Quality Standard Update on Dementia: For Consultation (NICE)

Posted on February 1, 2019 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence (NICE) has issued a draft quality standard on dementia prevention, and the assessment, management and health and social care support for persons living with dementia. It is expected to help drive … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NICE Guidelines, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest | Tagged Adults’ Health and Lifestyle, Advance Care Planning (ACP), Alternatives to Antipsychotic Drugs, Antipsychotics Limitation in Dementia, Assessment of Care Needs, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Care of People with Dementia: Quality Standard, Care Planning, Care Planning (Community), Care Planning in Dementia, Carer Support, Carer Support Services, Carer's Needs, Carer’s Needs Assessment, Choice and Control, Choice and Control Over Decisions, Choice in Health and Social Care, Commissioning Carer Support Services, Dementia Risk Factors, Dementia Risk Reduction and Prevention, Dementia: Quality Standard Consultation (2019), Distress, Distressed Behaviour, Healthy Lifestyles, Informed Choices, Lifestyle Risk Factors, Modifiable Risk Factors, Named Care Coordinators, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE)’s Quality Standard on Dementia: 2019 Draft For Consultation, Needs of Carers, Prevention Agenda, Quality Standard on Care of People with Dementia, Quality Statements, Reducing Agitation and Distress, Social Care, Structured Assessment (Pre- Non-Pharmacological or Pharmacological Treatment for Distress), Supporting People to Live Well With Dementia, Thinking Ahead - Advance Care Planning | Leave a comment

Antidepressants Not Recommended for Depression in People With Dementia (NIHR Signal / Cochrane Database)

Posted on January 12, 2019 by Dementia and Elderly Care News

Summary A National Institute for Health Research “Signal” expert commentary refers to a systematic review which indicates that antidepressants are unsuitable / unhelpful for the treatment of depression in persons living with dementia. Full Text Link Reference Antidepressants do not … Continue reading →

Posted in Acute Hospitals, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, NIHR, Person-Centred Care, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged Addenbrooke), Addenbrookes Hospital, Adverse Effects, Adverse Events, ALOIS: a Comprehensive Register of Dementia Studies, ALOIS: Cochrane Dementia and Cognitive Improvement's Specialized Register, ALOIS: the Cochrane Dementia and Cognitive Improvement Group, Antidepressants, Antidepressants for Agitation and Psychosis in Dementia, Antidepressants for Depression in Dementia, Antidepressants for Treating Depression in Dementia, Cambridge and Peterborough NHS Foundation Trust, Cambridge University Hospitals (Addenbrooke’s), Cochrane Database, Cochrane Database of Systematic Reviews, Cochrane Dementia and Cognitive Impairment Group, Cochrane UK, Department of Psychiatry: University of Cambridge, Drug Side-Effects, Inappropriate Medication, Inappropriate Prescribing, Later Life, Mental Health and Illness, National Institute for Health Research Signal, National Perinatal Epidemiology Unit (NPEU): University of Oxford, NIHR Signal, Older People’s Mental Health Service: Cambridge and Peterborough NHS Foundation Trust, Oxford Health NHS Foundation Trust, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Depression and Dementia, Preventable Adverse Events, Professor Martin Orrell, Professor Martin Orrell: Director of Institute of Mental Health at University of Nottingham; Division of Psychiatry and Applied Psychology: University of Nottingham, Psychotropic Drug Use (Antipsychotics Antidepressants Hypnotics Anxiolytics Anticonvulsants Antidementia Drugs), Reducing Inappropriate Prescribing of Antidepressants, Selective Serotonin Reuptake Inhibitors (SSRIs), University of Cambridge, University of Nottingham, University of Oxford | Leave a comment

Category Archives: Mental Health

Latest Dementia Assessment and Referral Data for 2018 (NHS England)

Antidepressants Not Recommended for Depression in People With Dementia (NIHR Signal / Cochrane Database)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites